A. Suijkerbuijk

发表

Cost-effectiveness of mandatory bicycle helmet use to prevent traumatic brain injuries and death

J. Polder, E. Over, G. D. de Wit, 2020, BMC Public Health.

The design of a Social Cost‐Benefit Analysis of preventive interventions for toxoplasmosis: An example of the One Health approach

M. Mangen, T. Feenstra, G. D. de Wit, 2018, Zoonoses and public health.

Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.

H. D. de Melker, J. Wallinga, L. Verhoef, 2012, Vaccine.

The economic burden of a Salmonella Thompson outbreak caused by smoked salmon in the Netherlands, 2012–2013

M. Bouwknegt, W. van Pelt, M. Mangen, 2016, European journal of public health.

Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections

H. Vennema, A. Meijer, W. van der Hoek, 2015, Influenza and other respiratory viruses.

Assessment of vaccine candidates for persons aged 50 and older: a review

H. D. de Melker, P. Krabbe, A. van Lier, 2013, BMC Geriatrics.

If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands

N. Mouter, E. Over, G. D. de Wit, 2022, Health Economics, Policy and Law.

A social cost-benefit analysis of two One Health interventions to prevent toxoplasmosis

J. Polder, M. Mangen, E. Over, 2019, PloS one.

Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country

H. D. de Melker, J. Polder, R. D. de Man, 2018, PloS one.

Current and future costs of COPD in the Netherlands

R. Hoogenveen, A. Wijga, M. Hoogendoorn, 2013 .

Meningococcal disease in the Netherlands. Background information for the Health Council

M. Knol, J. Kemmeren, A. Suijkerbuijk, 2017 .

Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners

M. Kretzschmar, R. Verheij, J. Joosten, 2011, BMC family practice.

Selenite enrichment broth to improve the sensitivity in molecular diagnostics of Salmonella.

M. Heck, A. Suijkerbuijk, A. V. D. van der Zanden, 2019, Journal of microbiological methods.

Gastrointestinal and Respiratory Illness in Children That Do and Do Not Attend Child Day Care Centers: A Cost-of-Illness Study

W. van Pelt, H. Smit, A. Lugnér, 2014, PloS one.

Ebola in the Netherlands, 2014–2015: costs of preparedness and response

J. Polder, M. Mangen, C. Swaan, 2018, The European Journal of Health Economics.

Cost of Nosocomial Outbreak Caused by NDM-1–Containing Klebsiella pneumoniae in the Netherlands, October 2015–January 2016

A. Suijkerbuijk, S. Lutgens, P. Schneeberger, 2017, Emerging infectious diseases.

The National Immunisation Programme in the Netherlands

H. J. Vriend, F. Mooi, L. Mollema, 2008 .

Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin

H. D. de Melker, A. Lugnér, A. Suijkerbuijk, 2022 .

The cost of Lyme borreliosis

C. C. van den Wijngaard, W. van Pelt, A. Hofhuis, 2017, European journal of public health.

Rabies vaccination strategies in the Netherlands in 2018: a cost evaluation

M. Mangen, C. Swaan, E. Over, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Doubling of the number of cases of tick bites and lyme borreliosis seen by general practitioners in the Netherlands].

J. Schellekens, S. den Boon, A. Suijkerbuijk, 2004, Nederlands tijdschrift voor geneeskunde.

The burden of Lyme borreliosis expressed in disability-adjusted life years.

J. Haagsma, C. C. van den Wijngaard, W. van Pelt, 2015, European journal of public health.

Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands

M. Kretzschmar, M. Mangen, S. McDonald, 2013, BMC Infectious Diseases.

Consumers' preferences for freezing of meat to prevent toxoplasmosis- A stated preference approach.

J. Polder, J. Veldwijk, M. Mangen, 2019, Meat science.

The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases

H. D. de Melker, C. Meijer, G. D. de Wit, 2017, Expert review of vaccines.

Consequences of restricted STI testing for young heterosexuals in the Netherlands on test costs and QALY losses.

F. van Aar, E. Over, H. Götz, 2017, Health policy.

Prospects of toxoplasmosis control by cat vaccination.

A. Suijkerbuijk, P. V. van Gils, A. B. Bonačić Marinović, 2019, Epidemics.

Effect of hepatitis A vaccination programs for migrant children on the incidence of hepatitis A in The Netherlands.

G. Sonder, J. V. van Steenbergen, A. Suijkerbuijk, 2009, European journal of public health.

Trading patients’ choice in providers for quality of maternity care? A discrete choice experiment amongst pregnant women

J. Struijs, J. Veldwijk, M. Lambooij, 2020, PloS one.

Ranking Preventive Interventions from Different Policy Domains: What Are the Most Cost-Effective Ways to Improve Public Health?

J. Polder, B. Staatsen, R. Maas, 2020, International journal of environmental research and public health.

[Significant decline of the number of invasive Haemophilus influenzae infections in the first 4 years after introduction of vaccination against H. influenzae type B in children].

R. Hirasing, A. Suijkerbuijk, I. Veldhuijzen, 2000, Nederlands tijdschrift voor geneeskunde.

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014

A. Lugnér, A. Suijkerbuijk, W. Ruijs, 2015 .

PP006 Ebola In The Netherlands: Costs Of Preparedness And Response

J. Polder, M. Mangen, C. Swaan, 2017, International Journal of Technology Assessment in Health Care.